In this study, we demonstrated that soluble factors produced by prostate cancer increase basal calcium as well as the proportion of cells with active fluctuations in calcium levels in RANKL-primed osteoclast precursors. This evidence concerns the gene TNFSF11 and prostate carcinoma.